Research map: Comparison of 24 Versus 46-Hour 5-FU Infusion Durations in the Perioperative FLOT Therapy for Gastric Cancer

Back to the article

Papers in this map

  1. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer · David Cunningham · 2006 · 6432 citations · Cited by this paper
  2. Balance Rehabilitation in Patients with Traumatic Brain Injury: A Scoping Review · 2026 · Related
  3. 5-Fluorouracil: mechanisms of action and clinical strategies · Daniel B. Longley · 2003 · 5404 citations · Cited by this paper
  4. Short-Term Association of Add-On Gosha-Jinki-Gan with Sleep and Nocturia Outcomes in Patients with Persistent Nocturia Despite Desmopressin: A Real-World Study · 2026 · Related
  5. Gastric cancer · Elizabeth Catherine Smyth · 2020 · 5032 citations · Cited by this paper
  6. Angular and Rotational Lower Limb Alignment Variations in Children: Practical Guidance for Paediatricians · 2026 · Related
  7. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial · Salah‐Eddin Al‐Batran · 2019 · 2702 citations · Cited by this paper
  8. Blood Transfusion and ABO Blood Groups in Sickle Cell Disease · 2026 · Related
  9. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology · Jaffer A. Ajani · 2022 · 1772 citations · Cited by this paper
  10. Serum YKL-40 in Non-ST-Segment Elevation Acute Coronary Syndrome: A Prospective Exploratory Emergency Department Study · 2026 · Related
  11. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · Florian Lordick · 2022 · 1526 citations · Cited by this paper
  12. Circulating miR-221/222 and Serum IL-23 in Treatment-Naïve Multiple Sclerosis: A Case–Control Study · 2026 · Related
  13. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer · Filippo Pietrantonio · 2019 · 497 citations · Cited by this paper
  14. Association Between Treatment-Emergent Pancreatic Volume Loss and Survival Outcomes in Patients with Metastatic Colorectal Cancer Receiving Bevacizumab · 2026 · Related
  15. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Meta-Analysis Group In Cancer. · E Levy · 1998 · 493 citations · Cited by this paper
  16. Epidemiological Trends and Clinical Implications: An 8-Year Retrospective Study from a Burn Rehabilitation Center in Taiwan · 2026 · Related
  17. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study · Kohei Shitara · 2023 · 388 citations · Cited by this paper
  18. A Novel Hemizygous CDX4 Missense Variant Identified in a Taiwanese Man with Severe Teratozoospermia · 2026 · Related
  19. Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer · Yelena Yuriy Janjigian · 2025 · 319 citations · Cited by this paper
  20. Serum Biomarkers as Predictors of Recurrence in Chronic Rhinosinusitis with Nasal Polyps · 2026 · Related
  21. Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma · Pooja R. Rohatgi · 2006 · 45 citations · Cited by this paper
  22. V-set and immunoglobulin domain containing 1 (VSIG1) as an emerging target for epithelial–mesenchymal transition of gastric cancer · Catalin-Bogdan Satala · 2022 · 19 citations · Cited by this paper
  23. Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer · Roberto Petrioli · 2019 · 16 citations · Cited by this paper
  24. Definition and Predictors of Early Recurrence in Neoadjuvantly Treated Esophageal and Gastroesophageal Adenocarcinoma: a Dual-Center Retrospective Cohort Study · Ingmar Florin Rompen · 2024 · 12 citations · Cited by this paper
  25. Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany · Rebekka Schirren · 2020 · 11 citations · Cited by this paper
  26. Beyond Gastric Specificity: V-Set and Immunoglobulin Domain-Containing 1 (VSIG1) in Digestive Tract Tumors · Catalin-Bogdan Satala · 2026 · 6 citations · Cited by this paper
  27. Prognostic Impact and Postoperative Management Following Poor Pathological Response to Perioperative FLOT in Resectable Gastric and GEJ Adenocarcinoma: A Systematic Review and Meta-Analysis · Ismaell Massalha · 2026 · 3 citations · Cited by this paper
  28. Efficacy of Perioperative FLOT Therapy in Locally Advanced Gastric Cancer and the Associated Prognostic Factors · Gül Sema Yıldıran Keskin · 2024 · 2 citations · Cited by this paper
  29. Real-World Predictors of Pathologic Response to FLOT in Patients with Resectable Gastric Cancer: A Retrospective Analysis · Gökşen İnanç İmamoğlu · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)